Results 111 to 120 of about 247,670 (219)

Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma [PDF]

open access: yes, 2009
Signaling through the Notch1 receptor has a pivotal role in early thymocyte development. Gain of Notch1 function results in the development of T-cell acute lymphoblastic leukemia in a number of mouse experimental models, and activating Notch1 mutations ...
Chiba Shigeru   +20 more
core   +1 more source

Therapeutic landscape of primary refractory and relapsed diffuse large B-cell lymphoma: Recent advances and emerging therapies

open access: yesJournal of Hematology & Oncology
Diffuse large B-cell lymphoma (DLBCL) is an aggressive, yet curable malignancy, that has had practice changing treatment approvals in both the frontline and relapsed setting in the last 5 years. Advent of novel therapeutic options in the recent years has
Allison M. Bock, Narendranath Epperla
doaj   +1 more source

Malignant lymphoma of the penis: report of two cases [PDF]

open access: yes, 1997
We report two cases of malignant lymphoma of the penis. A 64-year-old man presented with painful indurations of the penis. A computerized tomography (CT) scan showed a swollen retroperitoneal lymph node 5 cm in diameter. Penectomy confirmed the diagnosis
名出, 頼男   +7 more
core  

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

open access: yesNew England Journal of Medicine, 2002
B. Coiffier   +12 more
semanticscholar   +2 more sources

Childhood testicular diffuse large B-cell lymphoma

open access: yesКлиническая онкогематология, 2013
Non-Hodgkin’s lymphomas with primary testis involvement is a rare heterogeneous group of lymphoid tumours. In adults testicular lymphomas (TL) are characterized by aggressive clinical progression, frequent relapses and metastases to CNS, and poor ...
T. T. Valiev   +5 more
doaj   +1 more source

Neutrophil Extracellular Traps Induced by IL8 Promote Diffuse Large B-cell Lymphoma Progression via the TLR9 Signaling

open access: yesClinical Cancer Research, 2018
Purpose: More than 30% of patients with diffuse large B-cell lymphoma (DLBCL) experience treatment failure after first-line therapy. Neutrophil extracellular traps (NETs), a pathogen-trapping structure in tumor microenvironment, can promote the ...
M. Nie   +9 more
semanticscholar   +1 more source

LncRNA SNHG14/miR-5590-3p/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1/PD-L1 checkpoint

open access: yesCell Death and Disease, 2019
Diffuse large B cell lymphoma (DLBCL) is the commonest disorder derived from the B-lymphocytes. Inhibiting the immune checkpoint through naturalizing programmed death-1 (PD-1) and programmed death ligand 1 (PD-L1) is proved to be a successful therapeutic
Lina Zhao   +4 more
semanticscholar   +1 more source

Refractory diffuse large B-cell Lymphoma

open access: yesJournal of Taibah University Medical Sciences, 2023
Hajar Masrour   +15 more
doaj   +1 more source

Pathophysiology and molecular aspects of diffuse large B-cell lymphoma

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2012
Diffuse large B-Cell lymphoma is the most common subtype of non-Hodgkin lymphoma in the West. In Brazil, it is the fifth cause of cancer, with more than 55,000 cases and 26,000 deaths per year.
Gisele Rodrigues Gouveia   +2 more
doaj  

Non-Hodgkin’s Lymphoma of the Uterine Cervix [PDF]

open access: yes, 2012
Non Hodgkin’s Lymphoma (NHL) causes many deaths worldwide and its incidence is increasing. They occur commonly in middle aged and elderly people and are disseminated at diagnosis.
Kaler, AK, Vasudev, DS
core  

Home - About - Disclaimer - Privacy